HKEX eyes more global biotechs to build IPO hub
Amid a structural shift towards Asia, Insilico Medicine's IPO in December was a significant moment for the exchange, while French biotech TheraVectys is understood to be considering a listing.
February 24, 2026




.jpg&h=225&w=300&q=75&v=90ed771b68&c=1)




